Bizarre Patents
Mouthguard made at least partially from an edible candy
A mouthguard includes a U-shaped upper bite plate which removably fits over upper teeth of a person, with the entire upper bite plate being made from a soft, deformable and edible gummi candy.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 4656035 | Method of separating blood platelets A method of obtaining young blood platelets is disclosed which comprises adding at least one lectin to a mixture of blood platelets allowing this mixture to agglutinate, isolating the agglutinated product, and then removing the young agglutinated platelet... | 04/07/1987 |
| 4608255 | Biocompatible method for in situ production of functional platelets and product produced thereby lacking immunogenicity The present invention discloses the effect of ultraviolet (UV) radiation on platelet concentrates collected in a plastics container, particularly in a polypropylene bag. Samples irradiated at 310 nm for 30 minutes at a dose of 774 J/M2 show no ... | 08/26/1986 |
| 4505822 | Process for separating substances from one another using a fibrin gel filter There is disclosed a filter comprising fibrin in gel form, the gel having substantially uniform pore sizes, and the filter comprising means for retaining the shape of at least one surface of the gel against deformation when contacted by a flowing medium.... | 03/19/1985 |
| 4489162 | Fresh blood (unfixed) hematology control Hematologic control and calibration standards are disclosed which are essentially plasma-free. These controls are prepared by the suspension of red blood cells in an appropriate buffer containing a stabilization effective amount of disaccharides, and othe... | 12/18/1984 |
| 4485096 | Tissue-equivalent and method for preparation thereof A tissue-equivalent, useful in the treatment of burns or other skin wounds and in the fabrication of prostheses, is disclosed which is prepared from a hydrated collagen lattice contracted by a contractile agent, such as fibroblast cells or blood platelets... | 11/27/1984 |
| 4479896 | Method for extraction localization and direct recovery of platelet derived growth factor A process for the localization and direct recovery of active platelet derived growth factor (PDGF) from stained sodium dodecyl sulfate/polyacrylamide gels is provided. This technique allows the user to identify and obtain purified PDGF peptides without lo... | 10/30/1984 |
| 4471051 | Stabilization of neutrophils and platelets Neutrophils and platelets from human blood are stabilized for storage and subsequent reconstitution for use by reacting with a chemical cross-linking agent having functional groups reactive to form covalent linkages with the neutrophils or platelets, the ... | 09/11/1984 |
| 4455299 | Storage of blood platelets Blood platelet pH is maintained between 6.0 and 7.6 for up to at least five days in relatively low gas permeability containers, e.g., standard polyvinyl chloride containers, by exposing the container to an atmosphere having an oxygen content greater than ... | 06/19/1984 |
| 4447415 | Plasma-free medium for platelet storage Blood platelet concentrate in a plasma-free medium. Method for storage of blood platelets in a plasma-free medium which comprises centrifuging plasma to obtain a platelet pellet, removing the supernatant plasma, and resuspending the platelet pellet in a b... | 05/08/1984 |
| 4427651 | Enriched plasma derivative for enhancement of wound closure and coverage A sprayable preparation for accelerated hemostasis and optimized biochemical control of wound closure contains a powdery mixture of 15 to 60% by weight of thrombin, 5 to 80% by weight of a desiccating and stabilizing agent, viz., albumin, globulin and/or ... | 01/24/1984 |
| 4427650 | Enriched plasma derivative for advancement of wound closure and healing A preparation for accelerated hemostasis and optimized biochemical control of wound closure ("tissue adhesive") consists only of solid, powdery, biologically active constituents and contains 60 to 96% by weight of fibrinogen, which is largely liberated fr... | 01/24/1984 |
| 4405719 | Method of stabilizing platelets for determining multiple platelet parameters in reference control and calibrator compositions; diluents therefor; and combination stabilization procedures This invention utilizes for stabilization of platelets a combination of iodoacetamide and an iminodiacetic acid or salt thereof, together with a compatible bacteriostatic agent, in an aqueous electrolytic solution which is maintained at a preselected rang... | 09/20/1983 |
| 4390619 | Leukocyte or platelet storage using ion-exchange resins A method of storing and preserving the shelf life of leukocytes or platelets suitable for transfusion is extended by maintaining viable platelets having adequate ATP and pH levels using an insoluble polymer material as a source of weakly basic buffer ions... | 06/28/1983 |
| 4358394 | Process for preparing whole blood reference controls having long term stability A process for preparing whole blood reference controls having long term stability up to six months for devices using electronic means for whole blood determinations including platelet count and mean cell volume and red blood distribution width. The precon... | 11/09/1982 |
| 4344936 | Platelet composition having improved storage stability and method therefor There is disclosed, in one aspect, a composition for improving the storage stability of blood platelets comprising the platelets, a container for the platelets, and a sialyl compound having the structural formula (I) ##STR1## wherein Ac is an acetyl ... | 08/17/1982 |
| 4343793 | Process for obtaining intact and viable leucocytes and thrombocytes from blood A process for obtaining functionally and morphologically intact and viable leucocytes and thrombocytes from blood is disclosed. Erythrocytes are removed from the blood and then the leucocytes are separated by centrifugation and treated to remove trace amo... | 08/10/1982 |
| 4302355 | Platelet reference control This invention describes a novel method for preparing a stable suspension of individual blood platelets for use as a control in both manual and automatic platelet counting procedures.... | 11/24/1981 |
| 4219440 | Multiple analysis hematology reference control reagent and method of making the same A single diagnostic test reagent for use as a multiple-analysis hematology reference control for monitoring the precision and accuracy of measurements or determinations of red blood cell, white blood cell and platelet blood cell counting, hemoglobin conte... | 08/26/1980 |
| 4199954 | Method of storing physiological material Human cells or tissue in suspension or immersion in physiological solution are stored at a basic storage temperature of about 4° C., and periodically subjected to a higher temperature within the range of from 25°-37° C. for a period of time and at inte... | 04/29/1980 |
| 4157383 | Tanned thrombocytes The invention provides tanned thrombocytes, a process for preparing them and a diagnostic agent containing them to make evident antibodies of thrombocytes.... | 06/05/1979 |
| 4148878 | Inhibition of platelet aggregation with selected phosphoric acid esters A process for inhibiting platelet aggregation or thrombus formation by the addition of a member selected from the group consisting of a compound of the formula: ##STR1## WHEREIN X is an alkyl or alkenyl chain having 2-8 carbon atoms, one of whic... | 04/10/1979 |
| 4148879 | Inhibition of platelet aggregation with selected phosphonic and phosphinic acid esters A process for inhibiting platelet aggregation or thrombus formation by the addition of a member selected from the group consisting of a compound of the formula: ##STR1## WHEREIN X is an alkyl or alkenyl chain having 2-8 carbon atoms, one of whic... | 04/10/1979 |
| 4110161 | Process for inhibiting platelet aggregation A process for inhibiting platelet aggregation by the addition of a member selected from the group consisting of a compound of the formula: ##STR1## wherein Y is lower alkyl of 1 to 8 carbon atoms, cyclopropyl, ethinyl, -CF3, -F, -Cl, -OCH | 08/29/1978 |
| 4073723 | Anti-coagulating and filtering blood Blood is passed through a heparin coated mass of filamentous polyester resin, polyamide resin, polyacrylic resin, glass, steel, cotton or cellulose. Thereafter the blood is passed through a mass of the same filamentous material which is not heparin coated... | 02/14/1978 |
| 4059967 | Process for freezing blood platelets A frozen proteinaceous mass comprising blood platelets coated with glycerol-glucose, the frozen mass prepared by a process comprising: A. contacting blood platelets with an aqueous saline solution containing 4 to 7 weight percent glycerol and glucose 2 to 6 we... | 11/29/1977 |
| 4051236 | Inhibition of blood platelet aggregation The activity of PGE1 in inhibiting aggregation of blood platelets is enhanced by employing PGE1 in combination with certain inhibitors of cyclic 3',5'-adenosine monophosphate phosphodiesterase (PDE).... | 09/27/1977 |
| 4014993 | Inhibition of platelet aggregation with substituted phenylhydratropic acid compounds A process for inhibiting platelet aggregation by the addition of a member selected from the group consisting of a compound of the formula: ##STR1## WHEREIN IS PHENYL OR CYCLOHEXANE AND X and Y can be the same or different and are hydrogen, fluoro, c... | 03/29/1977 |
